Milestone Scientific (MLSS) Competitors $0.59 -0.01 (-2.01%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.60 +0.01 (+1.17%) As of 08/29/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLSS vs. MBOT, ELMD, BSGM, LNSR, PDEX, AVR, LAKE, PROF, RCEL, and LUCDShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Microbot Medical (MBOT), Electromed (ELMD), Biosig Technologies (BSGM), LENSAR (LNSR), Pro-Dex (PDEX), Anteris Technologies Global (AVR), Lakeland Industries (LAKE), Profound Medical (PROF), Avita Medical (RCEL), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Its Competitors Microbot Medical Electromed Biosig Technologies LENSAR Pro-Dex Anteris Technologies Global Lakeland Industries Profound Medical Avita Medical Lucid Diagnostics Microbot Medical (NASDAQ:MBOT) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership. Does the media prefer MBOT or MLSS? In the previous week, Microbot Medical had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 4 mentions for Microbot Medical and 0 mentions for Milestone Scientific. Microbot Medical's average media sentiment score of 0.59 beat Milestone Scientific's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media. Company Overall Sentiment Microbot Medical Positive Milestone Scientific Neutral Do institutionals & insiders believe in MBOT or MLSS? 16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 24.8% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, MBOT or MLSS? Microbot Medical has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Do analysts recommend MBOT or MLSS? Microbot Medical presently has a consensus target price of $9.00, indicating a potential upside of 136.22%. Milestone Scientific has a consensus target price of $1.25, indicating a potential upside of 111.83%. Given Microbot Medical's higher probable upside, equities research analysts plainly believe Microbot Medical is more favorable than Milestone Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, MBOT or MLSS? Milestone Scientific has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$11.44M-$0.58-6.57Milestone Scientific$9.08M5.10-$6.93M-$0.09-6.56 Is MBOT or MLSS more profitable? Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -76.27% -67.54% Milestone Scientific -52.01%-60.26%-40.23% SummaryMicrobot Medical and Milestone Scientific tied by winning 7 of the 14 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$46.36M$26.35M$5.69B$21.25BDividend YieldN/AN/A6.64%3.50%P/E Ratio-8.4312.9183.1929.27Price / Sales5.102.06515.1669.15Price / CashN/A12.8025.6618.27Price / Book5.362.0911.764.58Net Income-$6.93M-$5.31M$3.27B$997.71M7 Day Performance0.68%-0.54%1.13%0.77%1 Month Performance37.01%11.98%8.30%6.95%1 Year Performance-46.35%-22.06%62.26%11.66% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific1.784 of 5 stars$0.59-2.0%$1.25+111.8%-46.4%$46.36M$9.08M-8.4330MBOTMicrobot Medical1.5088 of 5 stars$4.16+8.1%$9.00+116.3%+333.0%$175.35MN/A-7.1720Analyst DowngradeHigh Trading VolumeELMDElectromed3.1215 of 5 stars$20.20-0.3%$33.50+65.8%+44.2%$169.40M$61.44M26.93160BSGMBiosig Technologies2.2006 of 5 stars$5.30+2.3%$10.00+88.7%+976.6%$162.75M$40K0.0050Gap UpLNSRLENSAR0.9658 of 5 stars$12.66-1.9%$15.00+18.5%+163.0%$153.96M$58.36M-3.01110News CoveragePositive NewsPDEXPro-Dex1.7999 of 5 stars$46.21+0.4%$56.00+21.2%+100.9%$150.09M$53.84M16.50140Upcoming EarningsAVRAnteris Technologies Global1.7969 of 5 stars$3.70-10.8%$16.50+345.9%N/A$149.66M$2.70M0.00138Positive NewsLAKELakeland Industries4.6716 of 5 stars$15.35-1.0%$26.00+69.4%-37.0%$147.48M$167.21M-5.102,100PROFProfound Medical1.7533 of 5 stars$4.67-1.5%$11.00+135.5%-51.1%$142.45M$11.84M-3.20150RCELAvita Medical1.5301 of 5 stars$4.65-4.7%$12.40+166.7%-53.6%$129.90M$64.25M-2.36130LUCDLucid Diagnostics2.7343 of 5 stars$1.16+5.5%$3.55+206.0%+57.4%$119.32M$4.35M-0.9770Gap Up Related Companies and Tools Related Companies Microbot Medical Alternatives Electromed Alternatives Biosig Technologies Alternatives LENSAR Alternatives Pro-Dex Alternatives Anteris Technologies Global Alternatives Lakeland Industries Alternatives Profound Medical Alternatives Avita Medical Alternatives Lucid Diagnostics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLSS Stock Alerts